Rapid Micro Biosystems, Inc.
NASDAQ:RPID
1.24 (USD) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|---|
Assets: | |||||
Current Assets: | |||||
Cash & Cash Equivalents
| 24.285 | 27.064 | 178.387 | 30.079 | 12.459 |
Short Term Investments
| 67.768 | 81.584 | 15.11 | 14.998 | 0.146 |
Cash and Short Term Investments
| 92.053 | 108.648 | 193.497 | 45.077 | 12.459 |
Net Receivables
| 5.583 | 5.369 | 5.005 | 5.784 | 4.919 |
Inventory
| 19.961 | 21.187 | 15.671 | 8.965 | 5.752 |
Other Current Assets
| 2.818 | 0.705 | 3.951 | 0.839 | 0.336 |
Total Current Assets
| 120.415 | 138.576 | 218.124 | 62.15 | 23.612 |
Non-Current Assets: | |||||
Property, Plant & Equipment, Net
| 19.072 | 20.881 | 11.304 | 7.052 | 7.592 |
Goodwill
| 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 0 | 1.4 | 1.3 | 0 | 0 |
Goodwill and Intangible Assets
| 0 | 1.4 | 1.3 | 0 | 0 |
Long Term Investments
| 3.195 | 29.79 | 9.966 | 0.1 | 0.152 |
Tax Assets
| 0 | -1.4 | -1.3 | 0 | 0 |
Other Non-Current Assets
| 0.77 | 1.403 | 1.775 | 0.695 | 0.332 |
Total Non-Current Assets
| 23.037 | 52.074 | 23.045 | 7.847 | 8.076 |
Total Assets
| 143.452 | 190.65 | 241.169 | 69.997 | 31.688 |
Liabilities & Equity: | |||||
Current Liabilities: | |||||
Account Payables
| 1.973 | 5.428 | 3.944 | 4.468 | 3.211 |
Short Term Debt
| 1.132 | 0.766 | 10.579 | 6.541 | 5.354 |
Tax Payables
| 0.252 | 0.329 | 0.781 | 0.688 | 0.613 |
Deferred Revenue
| 5.974 | 4.706 | 3.305 | 4.423 | 1.881 |
Other Current Liabilities
| 9.907 | 8.15 | 0.338 | 0.113 | 0.082 |
Total Current Liabilities
| 18.986 | 19.05 | 18.166 | 15.545 | 10.528 |
Non-Current Liabilities: | |||||
Long Term Debt
| 6.214 | 7.202 | 0 | 24.81 | 17.806 |
Deferred Revenue Non-Current
| 0 | 0 | 0 | 0.705 | 0.683 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | -0.705 | -0.683 |
Other Non-Current Liabilities
| 0.263 | 0.229 | 2.023 | 4.822 | 4.079 |
Total Non-Current Liabilities
| 6.477 | 7.431 | 2.023 | 29.632 | 21.885 |
Total Liabilities
| 25.463 | 26.481 | 20.189 | 45.177 | 32.413 |
Equity: | |||||
Preferred Stock
| 0 | 0 | 241.169 | 151.826 | 81.85 |
Common Stock
| 0.424 | 0.421 | 0.415 | 0.006 | 0.004 |
Retained Earnings
| -428.385 | -375.918 | -315.112 | -241.588 | -204.51 |
Accumulated Other Comprehensive Income/Loss
| -0.101 | -1.109 | -0.016 | 0.001 | 0 |
Other Total Stockholders Equity
| 546.051 | 540.775 | 294.524 | 114.575 | 121.931 |
Total Shareholders Equity
| 117.989 | 164.169 | 220.98 | 24.82 | -0.725 |
Total Equity
| 117.989 | 164.169 | 220.98 | 24.82 | -0.725 |
Total Liabilities & Shareholders Equity
| 143.452 | 190.65 | 241.169 | 69.997 | 31.688 |